Key points are not available for this paper at this time.
when subjected to 2.5 and 5% concentrations of chitosan. Our findings demonstrate that chitosan from BSF pupal exuviae could be a promising and novel therapeutic agent for drug development against resistant strains of bacteria.
Lagat et al. (Tue,) studied this question.